No Data
Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for Its Alcohol Substitute Beverage Product
Top Midday Decliners
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Express News | Clearmind Medicine Inc - While Phase I/Iia Clinical Trial Was Already Approved in Israel, Clearance From FDA Will Allow Trial to Be Initiated in US.
Express News | Clearmind Medicine Announces FDA Clearance For IND Application Of MEAI-Based CMND-100 Oral Capsule; Phase I/IIa Clinical Trial For Alcohol Use Disorder To Proceed In The US; Trial Already Approved In Israel
Clearmind Medicine Obtains IND Approval From the FDA to Start the Phase I/IIa Clinical Trial With Its Innovative Treatment for Alcoholism
No Data
